Benralizumab for eosinophilic granulomatosis with polyangiitis.

Saved in:
Bibliographic Details
Title: Benralizumab for eosinophilic granulomatosis with polyangiitis.
Authors: Cottu A; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France., Groh M; National Referral Center for Hypereosinophilic Syndrome (CEREO), Department of Internal Medicine, Hopital Foch, Suresnes, France., Desaintjean C; Department of Respiratory Diseases, Hospital for Cardiologie and Pneumology Louis Pradel, Lyon, France., Marchand-Adam S; Service de pneumologie et d'explorations fonctionnelles respiratoires, CHRU de Tours, Tours, France., Guillevin L; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France., Puechal X; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France., Beaumesnil S; Department of Internal Medicine and Infectious Diseases, University Hospital Centre, Bordeaux, France., Lazaro E; Department of Internal Medicine and Infectious Diseases, University Hospital Centre, Bordeaux, France., Samson M; Department of Internal Medicine and Clinical Immunology, University Hospital Centre, Dijon, France., Taille C; Reference Center for Rare Pulmonary Diseases and University of Paris Cité, Inserm 1152, Hospital Bichat - Claude-Bernard, Paris, France., Durel CA; Department of Internal Medicine, Edouard Herriot Hospital, Lyon, France., Diot E; Department of Internal Medicine, CHRU de Tours, Tours, France., Nicolas S; Department of Internal Medicine, CHRU de Tours, Tours, France., Guilleminault L; Department of Respiratory Medicine, University Hospital Centre Toulouse, Toulouse, France.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm U1291, CNRS U5282, Toulouse 2 University, Toulouse, France., Ebbo M; Departement of Internal Medicine, Assistance Publique - Hôpitaux de Marseille, Marseille, France., Cathebras P; Department of Internal Medicine, CHU, Saint-Etienne, France., Dupin C; Reference Center for Rare Pulmonary Diseases and University of Paris Cité, Hospital Bichat - Claude-Bernard, Paris, France., Yildiz H; Department of Internal Medicine and Infectious Diseases, Cliniques universitaires Saint-Luc, Bruxelles, Belgium., Belfeki N; Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Sud Ile-de-France, Melun, France., Pugnet G; Department of Internal Medicine and Clinical Immunology, CHU Toulouse Rangueil, Toulouse, France., Chauvin P; Department of Respiratory Diseases, University Hospital Centre Rennes, Rennes, France., Jouneau S; Department of Respiratory Diseases, IRSET UMR 1085, Rennes 1 University, Pontchaillou Hospital, Rennes, France., Lifermann F; Department of Internal Medicine, Centre Hospitalier de Dax, Dax, France., Martellosio JP; Department of Internal Medicine, Centre Hospitalier Universitaire de Poitiers, Poitiers, France., Cottin V; Department of Respiratory Diseases, Hospital for Cardiologie and Pneumology Louis Pradel, Lyon, France., Terrier B; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France benjamin.terrier@aphp.fr.; Université Paris Cité, Paris, France.
Corporate Authors: French Vasculitis Study Group
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Dec; Vol. 82 (12), pp. 1580-1586. Date of Electronic Publication: 2023 Aug 07.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1136/ard-2023-224624